It may have both an anti-spirochaete activity and an anti-inflammatory activity, similar to the treatment of rheumatoid arthritis. And caution is required if patients have certain heart conditions, diabetes, psoriasis etc. Best prescription savings card hydroxychloroquine 200mg Sulfasalazine plaquenil Chloroquine gram negative or positive Hydroxychloroquine and tiredness Hydroxychloroquine should be used during pregnancy and lactation only if the benefit justifies the potential perinatal risk. The additional risk imposed by hydroxychloroquine on pregnancy appears modest, and the drug should not be withheld when necessary. It does not appear to be safe during pregnancy. Hydroxychloroquine is in the antimalarial and 4-aminoquinoline families of medication. Hydroxychloroquine was approved for medical use in the United States in 1955. Availability. 200 mg tablets. Actions. Derivative closely related to chloroquine. Antimalarial activity is believed to be based on ability to form complexes with DNA of parasite, thereby inhibiting replication and transcription to RNA and DNA synthesis of the parasite. The most serious adverse effects affect the eye, with dose-related retinopathy as a concern even after hydroxychloroquine use is discontinued. The most common adverse effects are a mild nausea and occasional stomach cramps with mild diarrhea. Hydroxychloroquine sulfate pregnancy Hydroxychloroquine - Drugs and Lactation Database LactMed., Hydroxychloroquine - Wikipedia Actavis pharma plaquenilChloroquine for lupusBuy aralen lupusPlaquenil 200 cost It is not necessary to withdraw an antimalarial drug during pregnancy if the rheumatic disease is well controlled; however, the manufacturer of hydroxychloroquine advises avoiding use. HYDROXYCHLOROQUINE SULFATE Drug BNF content published.. HYDROXYCHLOROQUINE SULFATE. Hydroxychloroquine Oral Route Description and Brand.. Hydroxychloroquine sulfate tablets, USP are also indicated for the treatment of discoid and systemic lupus erythematosus, and rheumatoid arthritis. CONTRAINDICATIONS Use of this drug is contraindicated 1 in the presence of retinal or visual field changes attributable to any 4-aminoquinoline compound, 2 in patients with known hypersensitivity to 4-aminoquinoline compounds, and 3 for long-term therapy in children. OBJECTIVE To study maternal and fetal outcome of pregnancy in patients with lupus who were exposed to hydroxychloroquine HCQ. METHODS The case records of women n = 33 exposed to HCQ during their pregnancies n = 36 and of 53 control patients from a single lupus pregnancy centre were reviewed to determine lupus activity, obstetric experience, and infant outcome. Newer information indicates that infants exposed to hydroxychloroquine during breastfeeding receive only small amounts of the drug in breastmilk. In a small number of infants up to at least 1 year of age, careful follow-up found no adverse effects on growth, vision or hearing.